MiniMed reported Q4 net sales of $837 million growing 16% reported and 9% organic, with full-year FY2026 sales reaching $3.102 billion, a company first. The company launched FDA-cleared MiniMed Flex and MiniMed Go systems while expanding international markets and CGM attachment rates to 68%.